Hisanori Minakami
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Hisanori Minakami has a total of 152 co-authors. Here are the top co-authors by number of shared publications:
- Mamoru Morikawa
Department of Obstetrics and Gynecology, Kansai Medical University, Hirakata, Japan
8 shared publications - Kazutoshi Cho
Maternity and Perinatal Care Center, Hokkaido University Hospital, Sapporo, Japan
7 shared publications Takahiro Yamada
Department of Obstetrics, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan
7 shared publications- Takahiro Yamada
Division of Clinical Genetics, Hokkaido University Hospital, Sapporo, Japan
7 shared publications Mamoru Morikawa
Department of Obstetrics, Hokkaido University Graduate School of Medicine, Sapporo, Hokkaido, Japan
6 shared publicationsTakashi Yamada
Department of Obstetrics and Gynecology, Japan Community Health Care Organization Hokkaido Hospital, Sapporo, Japan
6 shared publications
Latest Publications
- Open Access
- 1 August 2019
- Published by Springer Nature in Clinical Epigenetics
- Vol. 11 (1) , 1-13
Placenta-specific epimutation at H19-DMR among common pregnancy complications: its frequency and effect on the expression patterns of H19 and IGF2
H19 and IGF2 genes are imprinted and involved in regulating fetal and placental growth. The H19 differentially methylated region (DMR) is paternally methylated and maternally unmethylated and regulates the imprinted expression of H19 and IGF2. Epimutation at the H19-DMR in humans results in congenital growth disorders, Beckwith-Wiedemann and Silver-Russell syndromes, when erroneously its maternal allele becomes methylated and its paternal allele becomes unmethylated, respectively. Although H19 and IGF2 have been assessed for their involvement in pregnancy complications including fetal growth restriction (FGR) and pregnancy-induced hypertension (PIH)/hypertensive disorder of pregnancy (HDP) intensively in the last decade, it is still not established whether epimutation at the H19-DMR in the placenta results in pathogenic conditions in pregnancy. We aimed to assess the frequency of H19-DMR epimutation and its effects on the allelic expression patterns of H19 and IGF2 genes among normal and abnormal pregnancy cases. We enrolled two independently collected sets of placenta samples from normal pregnancies as controls and common pregnancy complications, FGR and PIH (HDP). The first set consisted of 39 controls and 140 FGR and/or PIH cases, and the second set consisted of 29 controls and 62 cases. For these samples, we initially screened for DNA methylation changes at H19-DMR and IGF2-DMRs by combined bisulfite restriction analysis, and further analyzed cases with methylation changes for their allelic methylation and expression patterns. We identified one case each of FGR and PIH showing hypomethylation of H19-DMR and IGF2-DMRs only in the placenta, but not in cord blood, from the first case/control set. For the PIH case, we were able to determine the allelic expression pattern of H19 to be biallelically expressed and the H19/IGF2 expression ratio to be highly elevated compared to controls. We also identified a PIH case with hypomethylation at H19-DMR and IGF2-DMRs in the placenta from the second case/control set. Placental epimutation at H19-DMR was observed among common pregnancy complication cases at the frequency of 1.5% (3 out of 202 cases examined), but not in 68 normal pregnancy cases examined. Alteration of H19/IGF2 expression patterns due to hypomethylation of H19-DMR may have been involved in the pathogenesis of pregnancy complications in these cases.
- 1 August 2019
- Published by Springer Nature in Clinical Epigenetics
- Vol. 11 (1) , 1-13
Open AccessPlacenta-specific epimutation at H19-DMR among common pregnancy complications: its frequency and effect on the expression patterns of H19 and IGF2
H19 and IGF2 genes are imprinted and involved in regulating fetal and placental growth. The H19 differentially methylated region (DMR) is paternally methylated and maternally unmethylated and regulates the imprinted expression of H19 and IGF2. Epimutation at the H19-DMR in humans results in congenital growth disorders, Beckwith-Wiedemann and Silver-Russell syndromes, when erroneously its maternal allele becomes methylated and its paternal allele becomes unmethylated, respectively. Although H19 and IGF2 have been assessed for their involvement in pregnancy complications including fetal growth restriction (FGR) and pregnancy-induced hypertension (PIH)/hypertensive disorder of pregnancy (HDP) intensively in the last decade, it is still not established whether epimutation at the H19-DMR in the placenta results in pathogenic conditions in pregnancy. We aimed to assess the frequency of H19-DMR epimutation and its effects on the allelic expression patterns of H19 and IGF2 genes among normal and abnormal pregnancy cases. We enrolled two independently collected sets of placenta samples from normal pregnancies as controls and common pregnancy complications, FGR and PIH (HDP). The first set consisted of 39 controls and 140 FGR and/or PIH cases, and the second set consisted of 29 controls and 62 cases. For these samples, we initially screened for DNA methylation changes at H19-DMR and IGF2-DMRs by combined bisulfite restriction analysis, and further analyzed cases with methylation changes for their allelic methylation and expression patterns. We identified one case each of FGR and PIH showing hypomethylation of H19-DMR and IGF2-DMRs only in the placenta, but not in cord blood, from the first case/control set. For the PIH case, we were able to determine the allelic expression pattern of H19 to be biallelically expressed and the H19/IGF2 expression ratio to be highly elevated compared to controls. We also identified a PIH case with hypomethylation at H19-DMR and IGF2-DMRs in the placenta from the second case/control set. Placental epimutation at H19-DMR was observed among common pregnancy complication cases at the frequency of 1.5% (3 out of 202 cases examined), but not in 68 normal pregnancy cases examined. Alteration of H19/IGF2 expression patterns due to hypomethylation of H19-DMR may have been involved in the pathogenesis of pregnancy complications in these cases.
- Open Access
- 21 February 2018
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 15 (2) , 369
Different Risk Factors for Very Low Birth Weight, Term-Small-for-Gestational-Age, or Preterm Birth in Japan
From 1985 to 2013, the mean birth weight of infants in Japan decreased from 3120 g to 3000 g, and the low-birth-weight rate among live births increased from 6.3% to 9.6%. No prospective study has elucidated the risk factors for poor fetal growth and preterm birth in recent Japanese parents, such as increased parental age, maternal body figure, assisted reproductive technology (ART), and socioeconomic status. Participants were mother–infant pairs (n = 18,059) enrolled in a prospective birth cohort in Hokkaido, Japan from 2002 to 2013. Parental characteristics were obtained via self-reported questionnaires during pregnancy. Medical records helped identify very-low-birth-weight (VLBW; 2 increased the risk of PTB and term-SGA. The RR for low BMI was highest among mothers who have low educational level. Among various factors, appropriate nutritional education to maintain normal BMI is important to prevent PTB and term-SGA in Japan.
- 21 February 2018
- Published by MDPI AG in International Journal of Environmental Research and Public Health
- Vol. 15 (2) , 369
Open AccessDifferent Risk Factors for Very Low Birth Weight, Term-Small-for-Gestational-Age, or Preterm Birth in Japan
From 1985 to 2013, the mean birth weight of infants in Japan decreased from 3120 g to 3000 g, and the low-birth-weight rate among live births increased from 6.3% to 9.6%. No prospective study has elucidated the risk factors for poor fetal growth and preterm birth in recent Japanese parents, such as increased parental age, maternal body figure, assisted reproductive technology (ART), and socioeconomic status. Participants were mother–infant pairs (n = 18,059) enrolled in a prospective birth cohort in Hokkaido, Japan from 2002 to 2013. Parental characteristics were obtained via self-reported questionnaires during pregnancy. Medical records helped identify very-low-birth-weight (VLBW; 2 increased the risk of PTB and term-SGA. The RR for low BMI was highest among mothers who have low educational level. Among various factors, appropriate nutritional education to maintain normal BMI is important to prevent PTB and term-SGA in Japan.
- 29 May 2017
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (8) , 1350-1352
Everolimus in pregnancy: Case report and literature review
There have been few reports on the effects of everolimus on the fetus, but none of six infants with documented everolimus exposure in utero had congenital malformations. A 32‐year‐old nulliparous woman on everolimus (5.0 mg/day) for renal angiomyolipoma (AML) due to tuberous sclerosis complex (TSC) was found to be pregnant at gestational week (GW) 7–5/7, at which time everolimus was withheld. To control AML in this patient, transarterial embolization was performed in the right and left kidneys at GW 21 and 24, respectively, and everolimus was reinitiated at GW 25. The patient gave birth at GW 37 to a normally formed infant weighing 3057 g, but who had cardiac tumors thought to be rhabdomyomas due to inherited TSC. Thus, although data are still limited, everolimus may be promising with respect to teratogenicity. Everolimus concentration in the maternal and umbilical cord blood at birth was 1.1 ng/mL and 1.0 ng/mL, respectively.
- 29 May 2017
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (8) , 1350-1352
Everolimus in pregnancy: Case report and literature review
There have been few reports on the effects of everolimus on the fetus, but none of six infants with documented everolimus exposure in utero had congenital malformations. A 32‐year‐old nulliparous woman on everolimus (5.0 mg/day) for renal angiomyolipoma (AML) due to tuberous sclerosis complex (TSC) was found to be pregnant at gestational week (GW) 7–5/7, at which time everolimus was withheld. To control AML in this patient, transarterial embolization was performed in the right and left kidneys at GW 21 and 24, respectively, and everolimus was reinitiated at GW 25. The patient gave birth at GW 37 to a normally formed infant weighing 3057 g, but who had cardiac tumors thought to be rhabdomyomas due to inherited TSC. Thus, although data are still limited, everolimus may be promising with respect to teratogenicity. Everolimus concentration in the maternal and umbilical cord blood at birth was 1.1 ng/mL and 1.0 ng/mL, respectively.
- 19 April 2017
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (6) , 967-973
Effect of urine creatinine level during pregnancy on dipstick test
Aim: Dipstick results for proteinuria are affected by urine concentration, and thus urine creatinine concentration ([Cr]). This study was performed to determine whether spot urine [Cr] changes significantly during pregnancy, leading to a significantly different false‐negative rate (FNR) on dipstick test between trimester.Methods: The [Cr] and protein concentrations ([P]) were analyzed in 631 spot urine samples with negative/equivocal dipstick from 425 pregnant women. False‐negative dipstick was defined as [P] : [Cr] ratio (P/Cr) > 0.27 mg/mg.Results: Median [Cr] was 117 mg/dL (range, 6.5–326 mg/dL), 72 mg/dL (range, 4.3–477 mg/dL), and 73 mg/dL (range, 8.4–396 mg/dL) in the first (n = 96), second (n = 344), and third (n = 191) trimester urine samples, respectively (P = 0.000, Kruskal–Wallis). Both [P] and P/Cr increased significantly with advancing gestation. FNR 9.4% (18/191) in the third trimester was significantly higher than that of 0.0% (0/96) in the second trimester and that of 0.5% (2/344) in the third trimester. In the 20 urine samples with false‐negative dipstick, median [Cr] was 47.0 mg/dL (range, 11.0–358 mg/dL) and the proportion of samples with dilute urine, that is, [Cr] P = 0.046).Conclusions: Urine samples in the second and third trimesters were more likely to be diluted compared with the first trimester. This was associated with high FNR in third trimester urine samples.
- 19 April 2017
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (6) , 967-973
Effect of urine creatinine level during pregnancy on dipstick test
Aim: Dipstick results for proteinuria are affected by urine concentration, and thus urine creatinine concentration ([Cr]). This study was performed to determine whether spot urine [Cr] changes significantly during pregnancy, leading to a significantly different false‐negative rate (FNR) on dipstick test between trimester.Methods: The [Cr] and protein concentrations ([P]) were analyzed in 631 spot urine samples with negative/equivocal dipstick from 425 pregnant women. False‐negative dipstick was defined as [P] : [Cr] ratio (P/Cr) > 0.27 mg/mg.Results: Median [Cr] was 117 mg/dL (range, 6.5–326 mg/dL), 72 mg/dL (range, 4.3–477 mg/dL), and 73 mg/dL (range, 8.4–396 mg/dL) in the first (n = 96), second (n = 344), and third (n = 191) trimester urine samples, respectively (P = 0.000, Kruskal–Wallis). Both [P] and P/Cr increased significantly with advancing gestation. FNR 9.4% (18/191) in the third trimester was significantly higher than that of 0.0% (0/96) in the second trimester and that of 0.5% (2/344) in the third trimester. In the 20 urine samples with false‐negative dipstick, median [Cr] was 47.0 mg/dL (range, 11.0–358 mg/dL) and the proportion of samples with dilute urine, that is, [Cr] P = 0.046).Conclusions: Urine samples in the second and third trimesters were more likely to be diluted compared with the first trimester. This was associated with high FNR in third trimester urine samples.
- 19 April 2017
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (7) , 1152-1158
Serum placental growth factor and soluble fms‐like tyrosine kinase 1 at mid‐gestation in healthy women: Association with small‐for‐gestational‐age neonates
Aim: This study was performed to determine the associations between serum placental growth factor (PlGF) and soluble fms‐like tyrosine kinase 1 (sFlt‐1) levels at mid‐gestation with the risk of small‐for‐gestational‐age (SGA) neonates born at gestational week (GW) ≥ 36 in healthy women.Methods: PlGF and sFlt‐1 concentrations were determined at GW 24–27 in 183 women with births at GW ≥ 36, but without gestational diabetes mellitus and hypertension.Results: Thirteen (7.1%) SGA neonates were born. Median (range) GW at blood sampling was similar between women with and without SGA (25 [24–25] and 24 [24–27], respectively, P = 0.671). Pre‐pregnancy body mass index (BMI) and PlGF levels were significantly lower in women with than without SGA, while sFlt‐1 levels and sFlt‐1 : PlGF ratio (sFlt‐1/PlGF) did not differ significantly between the two groups. PlGF and sFlt‐1/PlGF, but not BMI or sFlt‐1, showed significant correlations with birthweight z‐score; the correlation was positive for PlGF and negative for sFlt‐1/PlGF. Women with PlGF level < 10th percentile and those with sFlt‐1/PlGF level > 90th percentile showed significantly increased risk of SGA compared to those with respective counterpart characteristics; relative risk was 3.8 (95% confidence interval, 1.3–11.3; 21% [4/19] vs 5.5% [9/164]) for PlGF and 7.9 (95% confidence interval, 3.0–20.8, 33.3% [6/18] vs 4.2% [7/165]) for sFlt‐1/PlGF.Conclusion: Maternal PlGF and sFlt‐1/PlGF determined during GW 24–27 were associated with the risk of SGA neonates born at GW ≥ 36, even in women with uncomplicated pregnancies.
- 19 April 2017
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (7) , 1152-1158
Serum placental growth factor and soluble fms‐like tyrosine kinase 1 at mid‐gestation in healthy women: Association with small‐for‐gestational‐age neonates
Aim: This study was performed to determine the associations between serum placental growth factor (PlGF) and soluble fms‐like tyrosine kinase 1 (sFlt‐1) levels at mid‐gestation with the risk of small‐for‐gestational‐age (SGA) neonates born at gestational week (GW) ≥ 36 in healthy women.Methods: PlGF and sFlt‐1 concentrations were determined at GW 24–27 in 183 women with births at GW ≥ 36, but without gestational diabetes mellitus and hypertension.Results: Thirteen (7.1%) SGA neonates were born. Median (range) GW at blood sampling was similar between women with and without SGA (25 [24–25] and 24 [24–27], respectively, P = 0.671). Pre‐pregnancy body mass index (BMI) and PlGF levels were significantly lower in women with than without SGA, while sFlt‐1 levels and sFlt‐1 : PlGF ratio (sFlt‐1/PlGF) did not differ significantly between the two groups. PlGF and sFlt‐1/PlGF, but not BMI or sFlt‐1, showed significant correlations with birthweight z‐score; the correlation was positive for PlGF and negative for sFlt‐1/PlGF. Women with PlGF level < 10th percentile and those with sFlt‐1/PlGF level > 90th percentile showed significantly increased risk of SGA compared to those with respective counterpart characteristics; relative risk was 3.8 (95% confidence interval, 1.3–11.3; 21% [4/19] vs 5.5% [9/164]) for PlGF and 7.9 (95% confidence interval, 3.0–20.8, 33.3% [6/18] vs 4.2% [7/165]) for sFlt‐1/PlGF.Conclusion: Maternal PlGF and sFlt‐1/PlGF determined during GW 24–27 were associated with the risk of SGA neonates born at GW ≥ 36, even in women with uncomplicated pregnancies.
- 24 December 2016
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 32 (7) , 1378-1386
Association of antenatal antithrombin activity with perinatal liver dysfunction: A prospective multicenter study
Background and Aim: Liver dysfunction with decreased antithrombin (AT) activity and/or thrombocytopenia is life threatening in pregnant women. Whether AT is clinically useful for prediction of liver dysfunction remains unclear.Methods: A total of 541 women were registered prospectively at gestational week 34.7 (20.0–41.4) with available data on antenatal AT and platelet count (PLC).Results: Liver dysfunction defined as serum aspartate aminotransferase > 45 IU/L concomitant with lactate dehydrogenase > 400 IU/L occurred in five women antenatally (≤ 2 weeks before delivery) and in 17 women post‐partum (within 1 week post‐partum). Median (5th–95th) antenatal value was 85 (62–110)% for AT and 202 (118–315) × 109/L for PLC in the 541 women and was significantly lower in women with than without perinatal liver dysfunction; 75 (51–108) versus 86 (62–110)% and 179 (56–244) versus 203 (121–316) × 109/L, respectively. Nineteen (86%) women with liver dysfunction showed AT ≤ 62% or thrombocytopenia (PLC ≤ 118 × 109/L) perinatally, but five lacked thrombocytopenia throughout the perinatal period. The best cut‐off (AT, 77%; PLC, 139 × 109/L) suggested by receiver operating characteristic curve gave antenatal AT and PLC sensitivity of 59% and 41% with positive predictive value of 8.6% and 14%, respectively, and combined use of AT and PLC improved sensitivity to 73% (16/22) with positive predictive value of 9.2% for prediction of perinatal liver dysfunction.Conclusions: Reduced AT not accompanied by thrombocytopenia can precede liver dysfunction. Clinical introduction of AT may enhance the safety of pregnant women.
- 24 December 2016
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 32 (7) , 1378-1386
Association of antenatal antithrombin activity with perinatal liver dysfunction: A prospective multicenter study
Background and Aim: Liver dysfunction with decreased antithrombin (AT) activity and/or thrombocytopenia is life threatening in pregnant women. Whether AT is clinically useful for prediction of liver dysfunction remains unclear.Methods: A total of 541 women were registered prospectively at gestational week 34.7 (20.0–41.4) with available data on antenatal AT and platelet count (PLC).Results: Liver dysfunction defined as serum aspartate aminotransferase > 45 IU/L concomitant with lactate dehydrogenase > 400 IU/L occurred in five women antenatally (≤ 2 weeks before delivery) and in 17 women post‐partum (within 1 week post‐partum). Median (5th–95th) antenatal value was 85 (62–110)% for AT and 202 (118–315) × 109/L for PLC in the 541 women and was significantly lower in women with than without perinatal liver dysfunction; 75 (51–108) versus 86 (62–110)% and 179 (56–244) versus 203 (121–316) × 109/L, respectively. Nineteen (86%) women with liver dysfunction showed AT ≤ 62% or thrombocytopenia (PLC ≤ 118 × 109/L) perinatally, but five lacked thrombocytopenia throughout the perinatal period. The best cut‐off (AT, 77%; PLC, 139 × 109/L) suggested by receiver operating characteristic curve gave antenatal AT and PLC sensitivity of 59% and 41% with positive predictive value of 8.6% and 14%, respectively, and combined use of AT and PLC improved sensitivity to 73% (16/22) with positive predictive value of 9.2% for prediction of perinatal liver dysfunction.Conclusions: Reduced AT not accompanied by thrombocytopenia can precede liver dysfunction. Clinical introduction of AT may enhance the safety of pregnant women.
- 19 December 2016
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (2) , 257-264
Liver dysfunction in women with pregnancy‐induced antithrombin deficiency
Aim: The aim of this study was to determine whether women with pregnancy‐induced antithrombin deficiency (PIATD) had higher risk of liver dysfunction in the absence of thrombocytopenia.Methods: We carried out a retrospective observational study at five centers in all 129 women with incidentally found PIATD among 5249 maternities and 129 control women without PIATD matched for number of fetuses and gestational week at delivery. PIATD was diagnosed in women with antenatal antithrombin (AT) activities of ≤75% followed by a further decrease to ≤65% peripartum. Liver dysfunction was defined as serum aspartate aminotransferase > 45 IU/L concomitant with lactate dehydrogenase > 400 IU/L. Thrombocytopenia was defined as platelet count < 120 × 109/L.Results: Thrombocytopenia (22% [28/129] vs 5.4% [7/129], P = 0.0001) and liver dysfunction (16% [20/129] vs 0.0% [0/129], P = 0.0000) occurred significantly more often in PIATD than in control women. Of the 20 women with liver dysfunction, 15 (75%) had PIATD, but not thrombocytopenia. Thus, even in the absence of thrombocytopenia, liver dysfunction occurred significantly more often in PIATD than in control women (15% [15/101] vs 0.0% [0/122], respectively, P = 0.0000). The relative risk (95% confidence interval) of liver dysfunction was 28.6 (1.64–500) for women with AT activity of 60–65% and 52.4 (3.17–865) for women with AT activity of <60%, compared to women with AT activity ≥66%.Conclusion: PIATD can occur in the absence of thrombocytopenia and PIATD women had higher risk of liver dysfunction even in the absence of thrombocytopenia.
- 19 December 2016
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (2) , 257-264
Liver dysfunction in women with pregnancy‐induced antithrombin deficiency
Aim: The aim of this study was to determine whether women with pregnancy‐induced antithrombin deficiency (PIATD) had higher risk of liver dysfunction in the absence of thrombocytopenia.Methods: We carried out a retrospective observational study at five centers in all 129 women with incidentally found PIATD among 5249 maternities and 129 control women without PIATD matched for number of fetuses and gestational week at delivery. PIATD was diagnosed in women with antenatal antithrombin (AT) activities of ≤75% followed by a further decrease to ≤65% peripartum. Liver dysfunction was defined as serum aspartate aminotransferase > 45 IU/L concomitant with lactate dehydrogenase > 400 IU/L. Thrombocytopenia was defined as platelet count < 120 × 109/L.Results: Thrombocytopenia (22% [28/129] vs 5.4% [7/129], P = 0.0001) and liver dysfunction (16% [20/129] vs 0.0% [0/129], P = 0.0000) occurred significantly more often in PIATD than in control women. Of the 20 women with liver dysfunction, 15 (75%) had PIATD, but not thrombocytopenia. Thus, even in the absence of thrombocytopenia, liver dysfunction occurred significantly more often in PIATD than in control women (15% [15/101] vs 0.0% [0/122], respectively, P = 0.0000). The relative risk (95% confidence interval) of liver dysfunction was 28.6 (1.64–500) for women with AT activity of 60–65% and 52.4 (3.17–865) for women with AT activity of <60%, compared to women with AT activity ≥66%.Conclusion: PIATD can occur in the absence of thrombocytopenia and PIATD women had higher risk of liver dysfunction even in the absence of thrombocytopenia.
- 17 December 2016
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (2) , 387-391
Echocardiography findings in a case with Ballantyne syndrome
Marked fluid retention occurs in Ballantyne syndrome, but few reports are available on changes in cardiac morphology in this syndrome. A woman with generalized edema, dyspnea, fetal hydrops (skin edema and ascites), thickened placenta, and elevated plasma B‐type natriuretic peptide level (344 pg/mL) was admitted to our hospital at gestational week (GW) 20+3. Blood pressure remained within the normal range. However, acute increases in left atrial volume index, pulmonary artery systolic pressure, and hyperdynamic left ventricular function (as evidenced by increased left ventricular ejection fraction to 74% with cardiac index of 5.1 L/min/m2) occurred preceding fetal death at GW 21+4 in the presence of increased inferior vena cava diameter (23 mm) and relatively low systemic vascular resistance of 752 dyn·s/cm5. These findings suggested life‐threatening heart failure and required cesarean delivery at GW 21+5 resulting in complete recovery. The placenta suggested cytomegalovirus infection.
- 17 December 2016
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 43 (2) , 387-391
Echocardiography findings in a case with Ballantyne syndrome
Marked fluid retention occurs in Ballantyne syndrome, but few reports are available on changes in cardiac morphology in this syndrome. A woman with generalized edema, dyspnea, fetal hydrops (skin edema and ascites), thickened placenta, and elevated plasma B‐type natriuretic peptide level (344 pg/mL) was admitted to our hospital at gestational week (GW) 20+3. Blood pressure remained within the normal range. However, acute increases in left atrial volume index, pulmonary artery systolic pressure, and hyperdynamic left ventricular function (as evidenced by increased left ventricular ejection fraction to 74% with cardiac index of 5.1 L/min/m2) occurred preceding fetal death at GW 21+4 in the presence of increased inferior vena cava diameter (23 mm) and relatively low systemic vascular resistance of 752 dyn·s/cm5. These findings suggested life‐threatening heart failure and required cesarean delivery at GW 21+5 resulting in complete recovery. The placenta suggested cytomegalovirus infection.
- Open Access
- 1 January 2016
- Published by Scitechnol Biosoft Pvt. Ltd. in Critical Care Obstetrics and Gynecology
- Vol. 2 (5)
Perinatal Mortality Rate in Weekend Birth in Japan
Background: It was unknown whether risk of perinatal mortality rate (PMR) was higher in weekend than week days births in Japan and how Japanese obstetricians attempted to reduce numbers of weekend births. Methods and Findings: Retrospective observational study on 301510 women registered in the Japan Society of Obstetrics and Gynecology registry system who gave birth to singleton infants at gestational week ≥ 22 between 2005 and 2009. The proportion of women giving birth vaginally vs. by caesarean section with and without uterotonics was determined according to day of the week. Perinatal mortality included stillbirth and early neonatal death within one week after live birth occurring on and after gestational week 22. The PMR was similar between weekdays and weekend births (2.0% [4898/240455] vs. 2.0% [1217/61055], respectively). The fractions of Sunday and Thursday births were smallest and largest, respective; the mean ± SD fractions of Saturday and Sunday births were 10.4 ± 0.2% and 9.9 ± 0.3%, respectively, while those of Monday, Tuesday, Wednesday, Thursday, and Friday births were 14.6 ± 0.3%, 16.5 ± 0.2%, 15.9% ± 0.4%, 17.1% ± 0.4%, and 15.6% ± 0.3% of all 301510 births, respectively. The numbers of vaginal births with uterotonics and of caesarean births per day were approximately double and ~3.6-fold greater for weekdays than for those for weekend, respectively. Conclusions: The PMR did not differ between births that occurred on weekdays and weekend. Frequent uterotonic use and caesarean delivery on weekdays explained the disproportionately reduced number of weekend births.
- 1 January 2016
- Published by Scitechnol Biosoft Pvt. Ltd. in Critical Care Obstetrics and Gynecology
- Vol. 2 (5)
Open AccessPerinatal Mortality Rate in Weekend Birth in Japan
Background: It was unknown whether risk of perinatal mortality rate (PMR) was higher in weekend than week days births in Japan and how Japanese obstetricians attempted to reduce numbers of weekend births. Methods and Findings: Retrospective observational study on 301510 women registered in the Japan Society of Obstetrics and Gynecology registry system who gave birth to singleton infants at gestational week ≥ 22 between 2005 and 2009. The proportion of women giving birth vaginally vs. by caesarean section with and without uterotonics was determined according to day of the week. Perinatal mortality included stillbirth and early neonatal death within one week after live birth occurring on and after gestational week 22. The PMR was similar between weekdays and weekend births (2.0% [4898/240455] vs. 2.0% [1217/61055], respectively). The fractions of Sunday and Thursday births were smallest and largest, respective; the mean ± SD fractions of Saturday and Sunday births were 10.4 ± 0.2% and 9.9 ± 0.3%, respectively, while those of Monday, Tuesday, Wednesday, Thursday, and Friday births were 14.6 ± 0.3%, 16.5 ± 0.2%, 15.9% ± 0.4%, 17.1% ± 0.4%, and 15.6% ± 0.3% of all 301510 births, respectively. The numbers of vaginal births with uterotonics and of caesarean births per day were approximately double and ~3.6-fold greater for weekdays than for those for weekend, respectively. Conclusions: The PMR did not differ between births that occurred on weekdays and weekend. Frequent uterotonic use and caesarean delivery on weekdays explained the disproportionately reduced number of weekend births.
- Open Access
- 30 September 2015
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 41 (12) , 1988-1990
Decreased baseline variability on fetal heart rate pattern in a fetus with heterotaxy syndrome
- 30 September 2015
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 41 (12) , 1988-1990
Open AccessDecreased baseline variability on fetal heart rate pattern in a fetus with heterotaxy syndrome